Noticias y publicaciones

Eventos

Publicaciones

  • Thiel J. et al. The FAP × CD3 bispecific antibody OMTX305 induces T cell–mediated antitumor effects in patient-derived ex vivo models of solid tumors. Sci. Adv. 2026.12(37):eaee2124. DOI: 10.1126/sciadv.aee2124
  • Fabre M. et al. OMTX705,  a Novel FAP-Targeting ADC  demonstrates Activity in Chemotherapy and PD1-Resistant  Solid Tumors Models. Clin Cancer Res. 2020.26(13):3420-3430. DOI: 10.1158/1078-0432.CCR-19-2238     
  • Pascual-Antón L. et al. Targeting carcinoma-associated mesotelial cells with antibody-drug conjugates in ovarian carcinomatosis. J. Pathol. 2023. 261(2):238-251. DOI: 10.1002/path.6170
  • Puerto-Camacho P. et al. Preclinical Efficacy of Endoglin-  Targeting Antibody-Drug Conjugates for the Treatment of  Ewing Sarcoma. Clin Cancer Res. 2019. 25(7):2228-2240. DOI: 10.1158/1078-0432.CCR-18-0936